Sanford Consortium For Regenerative Medicine
Sanford Consortium For Regenerative Medicine maintains stable operations with declining assets and no reported officer compensation.
EIN: 208009370 · La Jolla, CA · NTEE: H05 · Updated: 2026-03-28
Source Check Matrix
What Has Been Verified vs. What Needs Human Review
Identity resolved verified
Sanford Consortium For Regenerative Medicine is mapped to EIN 208009370.
IRS BMF exempt record needs review
Open IRS TEOS or BMF source before relying on exemption status.
IRS Pub 78 deductibility needs review
Pub 78 eligibility should be verified in IRS TEOS before money changes hands.
IRS automatic revocation needs review
Check the official auto-revocation bulk source or cached evidence before relying on current exemption.
IRS Form 990 index verified
13 stored filing years available.
Raw 990 source linked
Open ProPublica to verify the raw filing record and PDFs.
Filing depth verified
13 stored filing years available.
State charity registration manual confirmation
Open California Registry Search Tool; the workflow stops for human confirmation unless a stable source is cached.
Candid / GuideStar profile api pending
Candid API access is not configured; open manually and do not count as verified evidence.
Charity Navigator rating api pending
Charity Navigator API access is not configured; open manually and do not count as verified evidence.
Source and Resolution Links
Finish the Investigation Outside Our Dataset
When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.
IRS tax-exempt lookup
Verify exemption status and deductibility directly with the IRS.
IRS bulk evidence downloads
Check Pub 78, automatic revocation, 990-N, and Form 990 bulk evidence sources.
IRS EO BMF extract
Open the official Business Master File extract source for tax-exempt organization records.
ProPublica 990 source
Open the raw filing record and filing PDFs outside NonprofitSpending.
California Registry Search Tool
Confirm state charity registration or solicitation status where applicable.
Candid profile search
Look for GuideStar/Candid profile details, programs, leadership, and seals.
Charity Navigator search
Check whether another evaluator has ratings or impact context.
Workflow Engine
Queries We Should Resolve, Not Just Answer
Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.
Verify tax status Runnable
Triggered by: 501(c)(3), tax deductible, EIN
IRS status check plus source links
Verify official evidence Runnable
Triggered by: IRS Pub 78, BMF, revocation, 990 index, state registration
Official-source evidence matrix with human stops where a state portal must be checked.
Find source filings Runnable
Triggered by: 990 PDF, annual report, filing record
13 stored filing years plus ProPublica source
Crunch money signals Runnable
Triggered by: program expense ratio, CEO salary, revenue, grants
85% program spend, health grade C
Compare alternatives Runnable
Triggered by: best charities, similar nonprofits, compare
4 peer options surfaced
Resolve leadership and board Runnable
Triggered by: executive team, trustees, officer pay
Use 990 compensation disclosures and external profile links.
Donation decision copilot Runnable
Triggered by: should I donate, give or compare, charity safety
Eligibility, money signals, sources, peer context, and next action.
Grantmaker due diligence Runnable
Triggered by: foundation review, grant risk, grantee capacity
Foundation-style packet across filings, finances, governance, and gaps.
Impact evidence finder Runnable
Triggered by: outcomes, annual report, cost effectiveness
Separate actual impact evidence from raw 990 financial cleanliness.
Room for more funding Runnable
Triggered by: would my donation help, funding gap, marginal impact
Revenue trend, runway, surplus/deficit, and source follow-ups.
Operator transparency diagnostic Runnable
Triggered by: how does my nonprofit look to donors
Profile, filing, impact, and transparency improvements to earn trust.
| Metric | Value |
|---|---|
| Total Revenue | $10.0M |
| Total Expenses | $9.2M |
| Program Spending | 85% |
| CEO/Top Officer Pay | $8 |
| Net Assets | $37.0M |
| Transparency Score | 80/100 |
Search Intent Cockpit
Sanford Consortium For Regenerative Medicine Form 990, Revenue, CEO Pay, and IRS Filing Signals
Sanford Consortium For Regenerative Medicine is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Sanford Consortium For Regenerative Medicine in one place.
Form 990 Filing Summary
13 filing years are available, with latest revenue of $8.5M and expenses of $9.2M.
Revenue and Expenses
Sanford Consortium For Regenerative Medicine reported $8.5M in revenue and $9.2M in expenses, a deficit of $735K.
Executive Compensation
Top officer compensation appears as $8 in the stored analysis, with context against revenue and expenses below.
Charity Score and Red Flags
80/100 mission score, 3 red flags, and 3 strengths are shown from structured and AI review.
Is Sanford Consortium For Regenerative Medicine Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $7.8M (85%) |
Across stored filings, Sanford Consortium For Regenerative Medicine shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Some Concerns | Good filing record; 3 red flags identified |
| Mission spend | 85% to programs | Excellent |
| Financial durability | Grade C | 13 stored filing years |
| Peer context | Compare with Butte County Fire Safe Council | California and Category H context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Butte County Fire Safe Council →All California nonprofits
All Category H
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
La Jolla, CA nonprofitsCategory H in California
Health in California
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category H spending
Best Category H charities in California
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
The Chris And Melody Malachowsky Family Foundation
Campbell, CA · $28.9M revenue · Score 95/100
Compare side-by-sideSan Diego River Park Foundation
San Diego, CA · $4.1M revenue · Score 95/100
Compare side-by-sideAkshaya Patra Foundation Usa
Fremont, CA · $17.1M revenue · Score 92/100
Compare side-by-sideButte County Fire Safe Council
Paradise, CA · $8.5M revenue · Score 92/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Research Workflow
Turn this Form 990 profile into a donor-ready report
Request a concise report for Sanford Consortium For Regenerative Medicine with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.
Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.
Sanford Consortium For Regenerative Medicine directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Sanford Consortium For Regenerative Medicine
Sanford Consortium For Regenerative Medicine (EIN: 208009370) is a nonprofit organization based in La Jolla, CA, classified under NTEE code H05. The organization reported total revenue of $10.0M and total assets of $83.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Sanford Consortium For Regenerative Medicine's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Sanford Consortium For Regenerative Medicine is a mid-size nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -10.4%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $8.5M |
| Total Expenses | $9.2M |
| Surplus / Deficit | $-735,032 |
| Total Assets | $85.0M |
| Total Liabilities | $47.9M |
| Net Assets | $37.0M |
| Operating Margin | -8.7% |
| Debt-to-Asset Ratio | 56.4% |
| Months of Reserves | 110.9 months |
Financial Health Grade: C
In 2023, Sanford Consortium For Regenerative Medicine reported a deficit of $735K with expenses exceeding revenue, holds 110.9 months of operating reserves (strong position), has a debt-to-asset ratio of 56.4% (high leverage).
Financial Trends
Over 13 years of filings (2011–2023), Sanford Consortium For Regenerative Medicine's revenue has declined at a compound annual growth rate (CAGR) of -10.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +3.0% | +8.1% | -2.7% |
| 2022 | -0.7% | -7.1% | -4.2% |
| 2021 | +4.2% | +14.1% | -3.5% |
| 2020 | -2.5% | -4.0% | -2.1% |
| 2019 | -1.2% | +1.6% | -2.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2180 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Sanford Consortium For Regenerative Medicine with a Mission Score of 80 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Sanford Consortium For Regenerative Medicine allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $735K, with expenses exceeding revenue.
- Debt-to-asset ratio: 56.4%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation on its IRS 990 filings, which is highly unusual for an organization of its size ($8-9 million in annual expenses) and suggests that executive compensation may be paid by a related entity or not directly reported in this section, warranting further investigation for full transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Sanford Consortium For Regenerative Medicine's IRS 990 filings:
- Consistent 0% officer compensation reported on 990 Part VII, which is unusual for an organization of this scale and may obscure actual executive compensation arrangements.
- Significant expense spikes in 2016 ($19.8M) and 2015 ($12.5M) that considerably exceeded revenues, indicating potential large, unexplained expenditures or operational losses in those years.
- Steady decline in total assets from $117.2M in 2014 to $84.9M in 2023, which, while accompanied by a decrease in liabilities, warrants further investigation into asset management and long-term financial health.
Strengths
The following positive indicators were identified for Sanford Consortium For Regenerative Medicine:
- Consistent revenue generation, generally in the $8-9 million range annually, indicating stable operational funding.
- Long and consistent IRS 990 filing history (13 filings), demonstrating strong compliance and transparency in public reporting.
- Liabilities have decreased from $60.8M in 2014 to $47.9M in 2023, suggesting effective debt management and a strengthening balance sheet relative to liabilities.
Frequently Asked Questions about Sanford Consortium For Regenerative Medicine
Is Sanford Consortium For Regenerative Medicine a legitimate charity?
Sanford Consortium For Regenerative Medicine (EIN: 208009370) is a registered tax-exempt nonprofit based in California. Our AI analysis gives it a Mission Score of 80/100. It has 13 years of IRS 990 filings on record. Total revenue: $10.0M. 3 red flags identified. 3 strengths noted. Financial health grade: C.
How does Sanford Consortium For Regenerative Medicine spend its money?
Sanford Consortium For Regenerative Medicine directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Sanford Consortium For Regenerative Medicine tax-deductible?
Sanford Consortium For Regenerative Medicine is registered as a tax-exempt nonprofit (EIN: 208009370). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Sanford Consortium For Regenerative Medicine CEO make?
Sanford Consortium For Regenerative Medicine's highest-compensated officer earns $8 annually. The organization reported $10.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Sanford Consortium For Regenerative Medicine's spending goes to programs?
Sanford Consortium For Regenerative Medicine directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Sanford Consortium For Regenerative Medicine compare to similar nonprofits?
With a transparency score of 80/100 (Excellent), Sanford Consortium For Regenerative Medicine is above average for NTEE category H05 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Sanford Consortium For Regenerative Medicine located?
Sanford Consortium For Regenerative Medicine is headquartered in La Jolla, California and files with the IRS under EIN 208009370. It is classified under NTEE code H05.
How many years of IRS 990 filings does Sanford Consortium For Regenerative Medicine have?
Sanford Consortium For Regenerative Medicine has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $10.0M in total revenue.
How is executive compensation handled if 0% is reported on the 990?
The consistent reporting of 0% officer compensation across all available filings suggests that executive compensation might be paid by a related organization, or through a different mechanism not captured in Part VII of the 990, rather than directly by the Sanford Consortium For Regenerative Medicine itself. This warrants further inquiry to understand the full compensation structure.
What caused the significant expense spikes in 2016 and 2015?
In 2016, expenses were $19,832,456 against revenues of $8,578,381, and in 2015, expenses were $12,515,545 against revenues of $8,185,564. These periods show expenses significantly exceeding revenues, which could indicate major capital expenditures, specific research project costs, or other one-time outlays. A deeper dive into the detailed financial statements for those years would be necessary to understand the nature of these expenditures.
Why have total assets been steadily declining since 2014?
Total assets have decreased from $117,252,665 in 2014 to $84,972,160 in 2023. This consistent decline, while liabilities have also decreased, could be due to depreciation of fixed assets, strategic divestments, or the utilization of endowment funds. Understanding the composition of these assets and the reasons for their reduction would provide more insight into the organization's long-term financial strategy.
Filing History
IRS 990 filing history for Sanford Consortium For Regenerative Medicine showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Sanford Consortium For Regenerative Medicine's revenue has declined by 73.1%, moving from $31.4M to $8.5M. Total assets decreased by 37.5% over the same period, from $136.0M to $85.0M. Total functional expenses rose by 457.9%, from $1.6M to $9.2M. In its most recent filing year (2023), Sanford Consortium For Regenerative Medicine reported a deficit of $735K, with expenses exceeding revenue. The organization holds $47.9M in liabilities against $85.0M in assets (debt-to-asset ratio: 56.4%), resulting in net assets of $37.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $8.5M | $9.2M | $85.0M | $47.9M | — | — |
| 2022 | $8.2M | $8.5M | $87.3M | $49.9M | — | — |
| 2021 | $8.3M | $9.2M | $91.1M | $52.9M | — | View 990 |
| 2020 | $7.9M | $8.0M | $94.5M | $55.5M | — | View 990 |
| 2019 | $8.1M | $8.4M | $96.5M | $57.4M | — | View 990 |
| 2018 | $8.2M | $8.2M | $99.1M | $59.8M | — | View 990 |
| 2017 | $8.2M | $9.7M | $101.5M | $62.3M | — | View 990 |
| 2016 | $8.6M | $19.8M | $105.5M | $64.7M | — | View 990 |
| 2015 | $8.2M | $12.5M | $110.7M | $58.6M | — | View 990 |
| 2014 | $7.8M | $12.2M | $117.3M | $60.9M | — | View 990 |
| 2013 | $7.8M | $11.5M | $123.3M | $62.5M | — | View 990 |
| 2012 | $19.6M | $10.2M | $129.8M | $65.3M | — | View 990 |
| 2011 | $31.4M | $1.6M | $136.0M | $80.9M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $8.5M, expenses of $9.2M, and assets of $85.0M (revenue +3.0% year-over-year).
- 2022: Revenue of $8.2M, expenses of $8.5M, and assets of $87.3M (revenue -0.7% year-over-year).
- 2021: Revenue of $8.3M, expenses of $9.2M, and assets of $91.1M (revenue +4.2% year-over-year).
- 2020: Revenue of $7.9M, expenses of $8.0M, and assets of $94.5M (revenue -2.5% year-over-year).
- 2019: Revenue of $8.1M, expenses of $8.4M, and assets of $96.5M (revenue -1.2% year-over-year).
- 2018: Revenue of $8.2M, expenses of $8.2M, and assets of $99.1M (revenue +0.9% year-over-year).
- 2017: Revenue of $8.2M, expenses of $9.7M, and assets of $101.5M (revenue -4.8% year-over-year).
- 2016: Revenue of $8.6M, expenses of $19.8M, and assets of $105.5M (revenue +4.8% year-over-year).
- 2015: Revenue of $8.2M, expenses of $12.5M, and assets of $110.7M (revenue +4.6% year-over-year).
- 2014: Revenue of $7.8M, expenses of $12.2M, and assets of $117.3M (revenue +0.8% year-over-year).
- 2013: Revenue of $7.8M, expenses of $11.5M, and assets of $123.3M (revenue -60.4% year-over-year).
- 2012: Revenue of $19.6M, expenses of $10.2M, and assets of $129.8M (revenue -37.6% year-over-year).
- 2011: Revenue of $31.4M, expenses of $1.6M, and assets of $136.0M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Sanford Consortium For Regenerative Medicine:
Data Sources and Methodology
This transparency report for Sanford Consortium For Regenerative Medicine is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.